HTR6 and obesity due to melanocortin 4 receptor deficiency: However, 5-HT6R antagonists have also been demonstrated to reduce food intake and body weight gain in comparable proportions to 5-HT2CR agonists in preclinical studies [9,10,22,25] and represent a further opportunity for obesity treatment drug development.